| Revenue |
624.2 |
578.1 |
2,424.2 |
2,378.1 |
| Operating expenses |
|
|
|
|
| Medical provision costs |
-477.0 |
-445.4 |
-1,859.0 |
-1,827.4 |
| Gross profit |
147.2 |
132.7 |
565.2 |
550.7 |
| Distribution, selling and marketing costs |
-29.5 |
-27.0 |
-109.1 |
-106.6 |
| Administrative costs |
-71.0 |
-69.7 |
-289.7 |
-288.4 |
| Operating profit (EBIT) |
46.7 |
36.0 |
166.4 |
155.7 |
| Other income/(costs) |
0.0 |
0.2 |
1.4 |
1.6 |
| Interest income |
1.0 |
1.0 |
4.3 |
4.3 |
| Interest expense |
-16.6 |
-15.2 |
-65.4 |
-64.0 |
| Other financial income/(expense) |
-2.5 |
4.1 |
-5.9 |
0.7 |
| Total financial result |
-18.1 |
-10.1 |
-67.0 |
-59.0 |
| Share of profit of associates |
0.0 |
0.0 |
0.1 |
0.1 |
| Profit before income tax |
28.6 |
26.1 |
100.9 |
98.4 |
| Income tax |
-8.0 |
-7.3 |
-26.4 |
-25.7 |
| Profit for the period |
20.6 |
18.8 |
74.5 |
72.7 |
| |
|
|
|
|
| Profit attributable to: |
|
|
|
|
| Owners of the parent |
22.1 |
20.1 |
79.5 |
77.5 |
| Non-controlling interests |
-1.5 |
-1.3 |
-5.0 |
-4.8 |
| Profit for the period |
20.6 |
18.8 |
74.5 |
72.7 |
| |
|
|
|
|
| Earnings per share: |
|
|
|
|
| Basic, € |
0.147 |
0.134 |
0.527 |
0.514 |
| Diluted, € |
0.146 |
0.133 |
0.526 |
0.513 |
